Follow
Harsh Moolani
Harsh Moolani
University of Miami Miller School of Medicine
Verified email at wustl.edu
Title
Cited by
Cited by
Year
Novel synthesis of kanamycin conjugated gold nanoparticles with potent antibacterial activity
JN Payne, HK Waghwani, MG Connor, W Hamilton, S Tockstein, ...
Frontiers in microbiology 7, 177773, 2016
1492016
Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration
JB Lin, HV Moolani, A Sene, R Sidhu, P Kell, JB Lin, Z Dong, N Ban, ...
JCI insight 3 (7), 2018
522018
Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activity
JN Payne, VD Badwaik, HK Waghwani, HV Moolani, S Tockstein, ...
International Journal of Nanomedicine, 1917-1926, 2018
292018
WNT7A/B promote choroidal neovascularization
JB Lin, A Sene, LA Wiley, A Santeford, E Nudleman, R Nakamura, JB Lin, ...
Experimental eye research 174, 107-112, 2018
152018
Rates of fellow eye macular hole development during long term follow-up
PC Staropoli, HV Moolani, AM Elhusseiny, HW Flynn Jr, WE Smiddy
Clinical Ophthalmology, 47-52, 2023
32023
Increasing Sense of Purpose Reduces Loneliness in Long-Term Care Residents
H Moolani, A Balasubramanian, S Wheeler, SSM Ponna, Z Ali
Journal of the American Medical Directors Association 23 (3), B18, 2022
2022
Role of macrophage microRNA-150 in age-related macular degeneration
J Lin, HV Moolani, A Sene, R Sidhu, JB Lin, Z Dong, N Ban, DS Ory, ...
Investigative Ophthalmology & Visual Science 59 (9), 5558-5558, 2018
2018
MicroRNA-150 Promotes Pathological Angiogenesis in Age-Related Macular Degeneration by Targeting Stearoyl-CoA Desaturase-2
H Moolani
2018
UA35/7/1 Gatton Academy of Mathematics & Science in Kentucky Publications
WKU Archives
2017
Novel self-patented gold nanoparticle synthesis, characterization, and antibacterial susceptibility testing
H Moolani, J Payne, R Dakshinamurthy
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–10